AXIN2 and neoplasm: In fact, inactivating mutations or deletion of these Wnt inhibitors (e.g., AXIN2 and RNF43) have been previously identified in human CRCs (Giannakis et al., 2014, Cancer Genome Atlas Network, 2012, Yan et al., 2017), indicating their tumor suppressive roles in cancer.